| Matthew Wade Floersch, MD | |
|
1133 College Ave, Suite C-143, Manhattan, KS 66502-2770 | |
| (785) 537-4940 | |
| (785) 537-0836 |
| Full Name | Matthew Wade Floersch |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 1133 College Ave, Manhattan, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114993698 | NPI | - | NPPES |
| 200347230A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0431403 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meadowlark Hills Home Health | Manhattan, KS | Home health agency |
| Homecare & Hospice Inc | Manhattan, KS | Hospice |
| Ascension Via Christi Hospital Manhattain, Inc | Manhattan, KS | Hospital |
| Clay County Medical Center | Clay center, KS | Hospital |
| Geary Community Hospital | Junction city, KS | Hospital |
| Wamego Health Center | Wamego, KS | Hospital |
| Meadowlark Hills | Manhattan, KS | Nursing home |
| Via Christi Village Manhattan, Inc | Manhattan, KS | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centerpointe Physicians Pa | 7214284561 | 10 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
An Endocrine Society-led diabetes initiative's interactive tools earned top honors and two other Society programs won Silver in the ASAE 2015 Power of A Awards, the Society announced today.
Medical Action Industries Inc., a leading supplier of medical and disposable surgical products today announced that VHA Inc., the national health care network, honored Medical Action Industries as the Non-Pharmacy Supplier of the Year at its Annual Leadership Conference, May 15-17, in San Diego, Calif. Medical Action is a long-time supplier of Novation, VHA's health care supply contracting company.
A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus.
Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.
› Verified 4 days ago
| Entity Name | Manhattan Retirement Foundation Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386602274 PECOS PAC ID: 0648299107 Enrollment ID: O20080626000520 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
An Endocrine Society-led diabetes initiative's interactive tools earned top honors and two other Society programs won Silver in the ASAE 2015 Power of A Awards, the Society announced today.
Medical Action Industries Inc., a leading supplier of medical and disposable surgical products today announced that VHA Inc., the national health care network, honored Medical Action Industries as the Non-Pharmacy Supplier of the Year at its Annual Leadership Conference, May 15-17, in San Diego, Calif. Medical Action is a long-time supplier of Novation, VHA's health care supply contracting company.
A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus.
Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.
› Verified 4 days ago
| Entity Name | Centerpointe Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316439086 PECOS PAC ID: 7214284561 Enrollment ID: O20180718002264 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
An Endocrine Society-led diabetes initiative's interactive tools earned top honors and two other Society programs won Silver in the ASAE 2015 Power of A Awards, the Society announced today.
Medical Action Industries Inc., a leading supplier of medical and disposable surgical products today announced that VHA Inc., the national health care network, honored Medical Action Industries as the Non-Pharmacy Supplier of the Year at its Annual Leadership Conference, May 15-17, in San Diego, Calif. Medical Action is a long-time supplier of Novation, VHA's health care supply contracting company.
A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus.
Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Wade Floersch, MD 3016 Montana Ct, Manhattan, KS 66502-2328 Ph: (785) 539-4100 | Matthew Wade Floersch, MD 1133 College Ave, Suite C-143, Manhattan, KS 66502-2770 Ph: (785) 537-4940 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
An Endocrine Society-led diabetes initiative's interactive tools earned top honors and two other Society programs won Silver in the ASAE 2015 Power of A Awards, the Society announced today.
Medical Action Industries Inc., a leading supplier of medical and disposable surgical products today announced that VHA Inc., the national health care network, honored Medical Action Industries as the Non-Pharmacy Supplier of the Year at its Annual Leadership Conference, May 15-17, in San Diego, Calif. Medical Action is a long-time supplier of Novation, VHA's health care supply contracting company.
A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus.
Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.
› Verified 4 days ago
Dr. Roger P Reitz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave, Suite E-110, Manhattan, KS 66502 Phone: 785-537-2651 Fax: 785-537-4276 | |
Xiao Lu, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-3322 | |
Casey Poell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-3322 | |
Fadi V Bedros, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 College Ave, Building B, Suite 100, Manhattan, KS 66502 Phone: 785-565-9500 Fax: 785-565-9595 | |
Dr. Palmer Frank Meek, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1133 College Ave, Suite E-110, Manhattan, KS 66502 Phone: 785-537-2651 Fax: 785-537-4276 | |
Samuel Ornelas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 College Ave Ste C143, Manhattan, KS 66502 Phone: 785-539-7641 Fax: 785-537-7620 |